Barrowcliffe Susan E.

CIK 00016642511 companyBRISBANE, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001664251

Recent Transactions

45 trades

Exercise/Conversion
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2018-11-19$3.02/sh+40,000→ 49,375 total
Sale
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2018-11-19$30.04/sh−40,000→ 9,375 total
Exercise/Conversion
Aimmune Therapeutics, Inc.
Stock Option (right to buy)
2018-11-19−40,000→ 53,400 total
Award
Aimmune Therapeutics, Inc.
Stock Option (right to buy)
2018-03-04+56,250→ 56,250 total
Award
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2018-03-04+9,375→ 9,375 total
Sale
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2018-01-02$37.13/sh−24,700→ 25,300 total
Sale
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2018-01-02$37.12/sh−24,400→ 600 total
Exercise/Conversion
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2018-01-02$3.02/sh+75,000→ 75,000 total
Sale
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2018-01-02$37.86/sh−300→ 25,000 total
Sale
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2018-01-02$37.75/sh−600→ 0 total
Exercise/Conversion
Aimmune Therapeutics, Inc.
Stock Option (right to buy)
2018-01-02−75,000→ 93,400 total
Sale
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2018-01-02$37.78/sh−599→ 50,000 total
Sale
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2018-01-02$37.12/sh−24,401→ 50,599 total
Sale
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2017-09-25$25.00/sh−20,000→ 0 total
Exercise/Conversion
Aimmune Therapeutics, Inc.
Stock Option (right to buy)
2017-09-25−20,000→ 168,400 total
Exercise/Conversion
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2017-09-25$3.02/sh+20,000→ 20,000 total
Sale
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2017-09-06$22.00/sh−15,167→ 0 total
Exercise/Conversion
Aimmune Therapeutics, Inc.
Stock Option (right to buy)
2017-09-06−15,167→ 188,400 total
Exercise/Conversion
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2017-09-06$3.02/sh+15,167→ 15,167 total
Exercise/Conversion
Aimmune Therapeutics, Inc.
Stock Option (right to buy)
2017-09-05−3,223→ 203,567 total
Sale
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2017-09-05$22.00/sh−3,223→ 0 total
Exercise/Conversion
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2017-09-05$3.02/sh+3,223→ 3,223 total
Exercise/Conversion
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2017-07-27$3.02/sh+500→ 500 total
Sale
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2017-07-27$22.00/sh−500→ 0 total
Exercise/Conversion
Aimmune Therapeutics, Inc.
Stock Option (right to buy)
2017-07-27−500→ 206,790 total
Exercise/Conversion
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2017-07-25$3.02/sh+4,650→ 4,650 total
Exercise/Conversion
Aimmune Therapeutics, Inc.
Stock Option (right to buy)
2017-07-25−4,650→ 207,290 total
Sale
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2017-07-25$22.00/sh−4,650→ 0 total
Sale
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2017-07-24$22.00/sh−500→ 0 total
Exercise/Conversion
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2017-07-24$3.02/sh+500→ 500 total
Exercise/Conversion
Aimmune Therapeutics, Inc.
Stock Option (right to buy)
2017-07-24−500→ 211,940 total
Sale
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2017-07-21$22.00/sh−960→ 0 total
Exercise/Conversion
Aimmune Therapeutics, Inc.
Stock Option (right to buy)
2017-07-21−960→ 212,440 total
Exercise/Conversion
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2017-07-21$3.02/sh+960→ 960 total
Exercise/Conversion
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2017-07-03$3.02/sh+15,000→ 15,000 total
Sale
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2017-07-03$20.26/sh−15,000→ 0 total
Exercise/Conversion
Aimmune Therapeutics, Inc.
Stock Option (right to buy)
2017-07-03−15,000→ 213,400 total
Award
Aimmune Therapeutics, Inc.
Stock Option (right to buy)
2017-02-24+90,000→ 90,000 total
Exercise/Conversion
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2016-11-11$3.02/sh+20,000→ 20,000 total
Sale
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2016-11-11$25.00/sh−20,000→ 0 total
Exercise/Conversion
Aimmune Therapeutics, Inc.
Stock Option (right to buy)
2016-11-11−20,000→ 228,400 total
Sale
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2016-11-08$20.00/sh−15,000→ 0 total
Exercise/Conversion
Aimmune Therapeutics, Inc.
Stock Option (right to buy)
2016-11-08−15,000→ 248,400 total
Exercise/Conversion
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2016-11-08$3.02/sh+15,000→ 15,000 total
Award
Aimmune Therapeutics, Inc.
Stock Option (right to buy)
2016-02-26+80,000→ 80,000 total

Companies

Aimmune Therapeutics, Inc.
General Manager, Europe

Recent Filings

Address

C/O AIMMUNE THERAPEUTICS, INC. 8000 MARINA BOULEVARD, SUITE 300

BRISBANE, CA, 94005-1884

View on SEC.gov